MEDICREA ENTERS US MARKET

The MEDICREA Group, specialized in the design, manufacture, and marketing of orthopedic implants for spine surgery, announces the opening of a US subsidiary, MEDICREA USA Corporation. Establishing a subsidiary in the US represents a decisive strategic step for MEDICREA. The presence of a local subsidiary will allow the group to gain a foothold in a market that represents 84% of the world market for spinal implants. This market, estimated in 2004, at $3.227 billion by Merrill Lynch in a report published in August 2005 has exhibited a 20% annual growth rate over the past 10 years. Actus News (http://www.actusnews.com/communique.php?ID=ACTUS-0-6451)